Features
Excel add-in
New
PowerPoint add-in
New
Pricing
FAQ
Sign in
Sign up
Sign up
Low
Medium
High
Download PNG
Download SVG
Copy and edit
Revenue → Gross profit: $28.5B
Diabetes care → Revenue: $25.1B
Gross profit → Pretax profit: $14.9B
Pretax profit → Net profit: $12.1B
Gross profit → Sales & distribution: $8.2B
Obesity care → Revenue: $6.0B
Revenue → Cost of sales: $5.2B
Gross profit → R&D: $4.7B
Pretax profit → Tax: $3.0B
Rare disease → Revenue: $2.5B
Gross profit → Administrative costs: $0.7B
Financial income → Pretax profit: $0.3B
Other income → Gross profit: $0.0B
Rare disease: $2.5B
Revenue: $33.7B
Obesity care: $6.0B
Diabetes care: $25.1B
Cost of sales: $5.2B
Gross profit: $28.5B
Sales & distribution: $8.2B
R&D: $4.7B
Administrative costs: $0.7B
Other income: $0.0B
Pretax profit: $15.2B
Financial income: $0.3B
Tax: $3.0B
Net profit: $12.1B
created with SankeyArt.com
Rare disease
$2.5B
Revenue
$33.7B
31% Y/Y
Obesity care
$6.0B
Diabetes care
$25.1B
Cost of sales
$5.2B
26% Y/Y
Gross profit
$28.5B
31% Y/Y
Sales & distribution
$8.2B
23% Y/Y
R&D
$4.7B
35% Y/Y
Administrative costs
$0.7B
9% Y/Y
Other income
$17M
-88% Y/Y
Pretax profit
$15.2B
52% Y/Y
Financial income
$0.3B
Tax
$3.0B
55% Y/Y
Net profit
$12.1B
51% Y/Y
Novo Nordisk FY23 Income Statement
